Confidential Social Network Referrals for HIV Testing

NCT05967208 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2023-08-01

No results posted yet for this study

Summary

Despite worldwide efforts to promote HIV testing, rates of testing remain low. The purpose of this study is to evaluate the acceptability, efficacy, and cost-effectiveness of confidential SMS-based social network referrals for HIV testing as a means of reaching high-risk individuals and prompting them to test for HIV. To accomplish this purpose, the study has 5 specific aims:

Aim 1 will conduct qualitative, formative work to identify desirable provider- and client-side characteristics of a confidential SMS-based HIV testing referral system.

Aim 2 will adapt an existing mHealth system (mParis) to add CONSORT functionality.

Aim 3 will pilot-test the CONSORT system to collect preliminary data on the system's acceptability, performance, and potential efficacy.

Aim 4 will evaluate the acceptability and efficacy of CONSORT in a randomized controlled trial.

Aim 5 will evaluate the incremental cost-effectiveness of CONSORT vs. other referral options.

If CONSORT is shown to be acceptable, effective, and cost-effective, such mobile-phone supported, chain-referral methods could greatly improve the cost-effectiveness of HIV testing efforts.

Conditions

Interventions

BEHAVIORAL

CONSORT referrals

Participants will be offered SMS-based confidential social network referrals for HIV testing ("CONSORT referrals") to extend to any of their social and sexual network contacts.

BEHAVIORAL

Card referrals

Participants will be offered physical invitation cards ("card referrals") to extend to any of their social and sexual network contacts.

Sponsors & Collaborators

  • Duke University

    collaborator OTHER
  • Kilimanjaro Christian Medical Centre, Tanzania

    collaborator OTHER
  • University of South Carolina

    lead OTHER

Principal Investigators

  • Jan Ostermann, PhD · University of South Carolina

  • Nathan Thielman, MD · Duke University

  • Bernard Njau, PhD · Kilimanjaro Christian Medical Centre, Tanzania

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-10-01
Completion
2027-04-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05967208 on ClinicalTrials.gov